Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/quantum-leap-healthcare-collaborative-initiates-landmark-phase-2-recast-dcis-platform-trial-to-evaluate-alternative-dcis-treatments-with-atossa-therapeutics-havah-therapeutics-and-the-menarini-group-301971653.html
https://www.globenewswire.com/news-release/2022/12/20/2577055/0/en/Athenex-Announces-Quantum-Leap-Healthcare-Collaborative-Reports-Positive-Trial-Result-of-I-SPY2-Trial-for-Oral-Paclitaxel-in-Combination-with-PD-1-and-Carboplatin-in-Neoadjuvant-Br.html
https://www.clinicaltrialsarena.com/news/omeros-covid-trial-narsoplimab/
https://www.globenewswire.com/news-release/2022/08/15/2498064/0/en/ALX-Oncology-and-Quantum-Leap-Healthcare-Collaborative-Announce-the-Selection-of-Evorpacept-in-the-I-SPY-P1-TRIAL-in-Combination-with-Enhertu-in-Breast-Cancer.html
https://www.prnewswire.com/news-releases/quantum-leap-healthcare-collaborative-announces-termination-of-the-cyclosporine-treatment-arm-for-critically-ill-covid-19-patients-in-the-i-spy-covid-trial-301601761.html
https://www.prnewswire.com/news-releases/ambrx-biopharma-inc-and-quantum-leap-healthcare-collaborative-announce-the-inclusion-of-arx788-in-the-i-spy-2-2-phase-2-adaptive-clinical-trial-for-breast-cancer-301532054.html
https://www.prnewswire.com/news-releases/i-spy-covid-trial-sponsored-by-quantum-leap-healthcare-collaborative-suggests-no-clinical-benefit-with-addition-of-nebulized-zyesami-aviptadil-when-given-by-mouth-inhalation-in-critically-ill-patients-with-covid-19-301514508.html
https://www.clinicaltrialsarena.com/news/famotidine-celecoxib-i-spy-trial/